With a bunch of gene therapy and gene editing programs in clinical trials, CRISPR Therapeutics (NASDAQ: CRSP) has an impressive resume already, but it's just getting started. It's currently in the ...
This advertisement has not loaded yet, but your article continues below. Images of the tests showed what appeared to be a BMW sedan being destroyed and old models of tanks being blown up More than ...